Suppr超能文献

在真实环境中,关于屈光结果、伤口愈合、疼痛强度和视觉恢复时间,比较经上皮准分子激光角膜切削术(trans-PRK)和准分子激光角膜切削术(PRK)的早期临床结果。

Early clinical outcomes and comparison between trans-PRK and PRK, regarding refractive outcome, wound healing, pain intensity and visual recovery time in a real-world setup.

机构信息

Augenlaserzentrum Neu-Ulm, Edisonallee 19, 89231, Neu-Ulm, Germany.

出版信息

BMC Ophthalmol. 2021 Apr 16;21(1):181. doi: 10.1186/s12886-021-01941-3.

Abstract

PURPOSE

To compare early clinical outcomes of single-step transepithelial photorefractive keratectomy (tPRK) and photorefractive keratectomy (PRK) regarding refractive outcome, visual acuity, wound healing, pain intensity and visual recovery time.d.

METHODS

In this prospective clinical observational study 200 eyes of 100 consecutive patients with mild to moderate myopia with or without mild astigmatism were included. One hundred eyes each were either treated with StreamLight™ tPRK or PRK with the WaveLight® EX500 excimer laser. Visual acuity (Decimal) was assessed preoperatively and at day 4, 7 and 6 weeks postoperatively. Wound healing (hours between surgery and complete epithelial closure) was monitored at the slit lamp. At day 4, patients subjectively rated the maximum pain intensity within the last 4 days using a numerical pain rating scale (0-15).

RESULTS

Visual recovery was significantly faster in the tPRK group. At days 4 and 7, the mean monocular UCDVA was significantly better in the tPRK group than in the PRK group (p < 0.001). Four days after surgery 72 % of eyes in the tPRK group but no eye in the PRK had a UCDVA of 0.7 or better. At six weeks postoperatively, a UCDVA of 1.0 or better was achieved in both groups. Complete epithelial wound closure was achieved significantly faster in the tPRK group (p < 0.0001) and maximum pain level within the first 4 days after surgery was significantly lower in the tPRK group (p < 0.0001). No patient had lost a line of BCDVA and no complications or adverse effects were observed.

CONCLUSIONS

According to our early clinical results, both treatments options appear to be safe and effective methods for the correction of low to moderate myopia with and without astigmatism. However, in our study, StreamLight™ tPRK offered faster visual recovery and epithelial healing and was associated with less pain compared to PRK. It can therefore be considered a good treatment option for patients who refuse or are not eligible for Femto-LASIK, but at the same time demand a faster and more comfortable recovery time than PRK can offer.

摘要

目的

比较单步经上皮准分子激光角膜切削术(tPRK)和准分子激光角膜切削术(PRK)在屈光结果、视力、伤口愈合、疼痛强度和视觉恢复时间方面的早期临床结果。

方法

在这项前瞻性临床观察研究中,纳入了 100 例连续患者的 200 只眼,这些患者患有轻度至中度近视,伴有或不伴有轻度散光。每只眼各用 StreamLight™ tPRK 或 WaveLight® EX500 准分子激光进行治疗。在术前和术后第 4、7 和 6 周评估视力(十进制)。使用裂隙灯监测伤口愈合(手术与完全上皮闭合之间的小时数)。术后第 4 天,患者使用数字疼痛评分量表(0-15)主观评估过去 4 天内的最大疼痛强度。

结果

tPRK 组的视觉恢复明显更快。在第 4 天和第 7 天,tPRK 组的平均单眼 UCDVA 明显优于 PRK 组(p<0.001)。术后第 4 天,tPRK 组 72%的眼而 PRK 组没有眼的 UCDVA 达到 0.7 或更好。术后 6 周,两组均达到 UCDVA 1.0 或更好。tPRK 组的上皮完全愈合时间明显更快(p<0.0001),术后前 4 天的最大疼痛水平明显更低(p<0.0001)。没有患者失去一行 BCDVA,也没有观察到并发症或不良反应。

结论

根据我们的早期临床结果,这两种治疗方法似乎都是治疗低中度近视伴或不伴散光的安全有效方法。然而,在我们的研究中,与 PRK 相比,StreamLight™ tPRK 提供了更快的视觉恢复和上皮愈合,并与更少的疼痛相关。因此,对于拒绝或不适合 Femto-LASIK 但同时要求比 PRK 更快、更舒适的恢复时间的患者,它可以被认为是一种较好的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/8052644/2254a25cf74e/12886_2021_1941_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验